Ya‐Wen Lin

3.0k total citations
78 papers, 2.4k citations indexed

About

Ya‐Wen Lin is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ya‐Wen Lin has authored 78 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 17 papers in Cancer Research and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Ya‐Wen Lin's work include Epigenetics and DNA Methylation (25 papers), Cancer-related gene regulation (21 papers) and Wnt/β-catenin signaling in development and cancer (12 papers). Ya‐Wen Lin is often cited by papers focused on Epigenetics and DNA Methylation (25 papers), Cancer-related gene regulation (21 papers) and Wnt/β-catenin signaling in development and cancer (12 papers). Ya‐Wen Lin collaborates with scholars based in Taiwan, China and United States. Ya‐Wen Lin's co-authors include Yu‐Lueng Shih, Hung‐Cheng Lai, Ming‐De Yan, Cheng‐Chang Chang, Tang‐Yuan Chu, Mu‐Hsien Yu, Yijuang Chern, Rui Huang, Jin‐Chuan Sheu and Chung‐Bao Hsieh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ya‐Wen Lin

75 papers receiving 2.4k citations

Peers

Ya‐Wen Lin

ONCOL

EPIDE

GENET

Jueng Soo You South Korea

Marcus D. Goncalves United States

Bilian Jin China

Giang Huong Nguyen United States

Shing Chuan Hooi Singapore

Heather M. O’Hagan United States

Stefania Gelmini Italy

Éric Hervouet France

Jing Tan China

Motoko Unoki Japan

Jueng Soo You South Korea

Ya‐Wen Lin

2.0k ×1.2

459 ×0.7

269 ×0.8

ONCOL

172 ×0.5

EPIDE

247 ×1.2

GENET

Citations per year, relative to Ya‐Wen Lin Ya‐Wen Lin (= 1×) peers Jueng Soo You

Countries citing papers authored by Ya‐Wen Lin

Since Specialization

Citations

This map shows the geographic impact of Ya‐Wen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Wen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Wen Lin more than expected).

Fields of papers citing papers by Ya‐Wen Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Wen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Wen Lin. The network helps show where Ya‐Wen Lin may publish in the future.

Co-authorship network of co-authors of Ya‐Wen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Wen Lin. A scholar is included among the top collaborators of Ya‐Wen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Wen Lin. Ya‐Wen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Ya‐Wen, Christelle Dubey, Jean‐Louis Reymond, et al.. (2025). Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma. Oncogenesis. 14(1). 28–28.

Cheng, Cong, Ya‐Wen Lin, & Jian Dai. (2025). Revisiting the Relationship Between CEO Characteristics and Firm Internationalization: Evidence From a Machine Learning Approach. Managerial and Decision Economics. 46(5). 2855–2868.

Chang, Shan‐Yueh, et al.. (2024). Promoter hypermethylation-mediated downregulation of PAX6 promotes tumor growth and metastasis during the progression of liver cancer. Clinical Epigenetics. 16(1). 174–174.

Guo, Jianhui, Ya‐Wen Lin, Le Yang, et al.. (2023). Life-course fertility and multimorbidity among middle-aged and elderly women in China: Evidence from China health and retirement longitudinal study. Frontiers in Public Health. 11. 1090549–1090549. 3 indexed citations

Lin, Ya‐Wen, et al.. (2023). The risk of suicidal intention in severe mental illness: An ecological perspective. Psychology and Psychotherapy Theory Research and Practice. 96(4). 1044–1061. 1 indexed citations

Chang, Shan‐Yueh, Yu‐Lueng Shih, Ying‐Chieh Chen, et al.. (2023). SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer. Cancers. 15(8). 2207–2207. 6 indexed citations

Li, Guo‐Bo, Xingyan Xu, Le Yang, et al.. (2023). Exploring the association between circRNA expression and pediatric obesity based on a case–control study and related bioinformatics analysis. BMC Pediatrics. 23(1). 561–561. 3 indexed citations

Cai, Yingying, Jianhui Guo, Xingyan Xu, et al.. (2022). Circ_0000284: A risk factor and potential biomarker for prehypertension and hypertension. Hypertension Research. 46(3). 720–729. 3 indexed citations

Chang, Shan‐Yueh, et al.. (2020). Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells. International Journal of Molecular Sciences. 21(15). 5425–5425. 5 indexed citations

10.

Chang, Shan‐Yueh, et al.. (2019). Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells. International Journal of Molecular Sciences. 20(23). 5914–5914. 19 indexed citations

11.

Lin, Ming-Hung, et al.. (2019). Stroke risks in women with dysmenorrhea by age and stroke subtype. PLoS ONE. 14(11). e0225221–e0225221. 5 indexed citations

12.

Shyu, Huey-Wen, Jing-Ruey Joanna Yeh, Ya‐Wen Lin, et al.. (2018). Anti-proliferative activity of biochanin A in human osteosarcoma cells via mitochondrial-involved apoptosis. Food and Chemical Toxicology. 112. 194–204. 48 indexed citations

13.

Lin, Ya‐Wen, Ming‐De Yan, Yu‐Lueng Shih, & Chung-Bao Hsieh. (2009). The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma. European Journal of Cancer. 45(11). 2041–2049. 15 indexed citations

14.

Lin, Jin‐Ding, et al.. (2008). Received, understanding and satisfaction of National Health Insurance premium subsidy scheme by families of children with disabilities: A census study in Taipei City. Research in Developmental Disabilities. 30(2). 275–283. 34 indexed citations

15.

Lai, Hung‐Cheng, Hsin‐Yi Lee, Wei‐Hsin Lin, et al.. (2008). Valproic acid resensitizes cisplatin‐resistant ovarian cancer cells. Cancer Science. 99(6). 1218–1226. 58 indexed citations

16.

Lin, Ya‐Wen, et al.. (2007). Epigenetic silencing of SFRP1 in hepatocellular carcinoma. Cancer Research. 67. 1147–1147. 1 indexed citations

17.

Lai, Hung‐Cheng, Ya‐Wen Lin, Cheng‐Chang Chang, et al.. (2006). Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecologic Oncology. 104(3). 629–635. 41 indexed citations

18.

Shih, Yu‐Lueng, et al.. (2006). Promoter methylation of the secreted frizzled‐related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Cancer. 107(3). 579–590. 85 indexed citations

19.

Huang, Nai-Kuei, Ya‐Wen Lin, Chuen-Lin Huang, Robert O. Messing, & Yijuang Chern. (2001). Activation of Protein Kinase A and Atypical Protein Kinase C by A2A Adenosine Receptors Antagonizes Apoptosis Due to Serum Deprivation in PC12 Cells. Journal of Biological Chemistry. 276(17). 13838–13846. 84 indexed citations

20.

Wu, Ming‐Shiang, Ming‐Chu Chang, Shih‐Pei Huang, et al.. (2000). Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes and Cancer. 30(1). 80–86. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact